Uncategorized
Global Uveal Melanoma Pipeline Review, H1 2016 – Analysis, Technologies & Forecasts Report – Key Vendors: Aura Biosciences, Novartis, Pfizer – Research and Markets
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Uveal Melanoma - Pipeline Review, H1 2016" report to their offering. The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and
